| BRIEF COMMUNICATION |
|
| Year : 2011 | Volume
: 15
| Issue : 7 | Page : 246-247 |
|
|
Growth hormone in the management of female infertility
Navneet Magon1, Swati Agrawal2, Sonia Malik3, KM Babu1
1 Department of Obstetrics and Gynaecology, Air Force Hospital, Kanpur, Uttar Pradesh, India
2 Department of Obstetrics and Gynecology, G. R. Medical College and Kamla Raja Hospital, Gwalior, Madhya Pradesh, India
3 Southend Fertility and IVF Centre, Holy Angels Hospital, New Delhi, India
Correspondence Address:
Navneet Magon
Obstetrician, Gynecologist and Endoscopic Surgeon, Department of Obstetrics and Gynaecology, Air Force Hospital, Kanpur, Uttar Pradesh
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2230-8210.84876
|
|
|
Growth hormone (GH) is involved in the regulation of male and female infertility and has been used in the management of both male and female infertility. GH is also produced by the ovary apart from it being produced from pituitary. GH helps in monofollicular growth. GH therapy is one of the adjuvant treatment used in ovarian stimulation and Assisted Reproductive Technologies Assisted Reproductive Technology (ART). GH supplementation has been shown to improve pregnancy rates in poor responders. Growth hormone cotherapy has a definite role to play in ovarian stimulation and is effective in appropriately selected cases. However, it cannot be recommended indiscriminately in every patient undergoing ovarian stimulation or assisted reproductive technology. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
